DSDaiki Soma

Daiki Soma

*This is an algorithmically generated author record based on publicly available information.

Daiki Soma has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Burcin Ekser

    Division of Transplantation, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN

    2 shared publications
  • Jonathan A. Fridell

    Department of Surgery, Indiana University School of Medicine, Indianapolis, USA

    2 shared publications
  • Marco Lacerda

    Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN

    2 shared publications
  • Marwan Ghabril

    Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN

    2 shared publications
  • Plamen Mihaylov

    Division of Transplantation, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN

    2 shared publications
  • Yujin Park

    Division of Transplantation, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN

    2 shared publications

Latest Publications

  • Open Access

    Renoportal Anastomosis for Portal Inflow Reconstruction During Liver Transplantation: A Single-Center Case Series From Northeastern Brazil

    by Raul Valerio Ponte, Emmanuel Nogueira, José Airton Lopes Filho, Francisco Alan Barbosa Leal, Themistocles Mesquita Teles de Carvalho, Camilla Bezerra Bastos Limeira, Vicente Bruno de Freitas Guimarães, Ingrid Sousa Barros, João Bernardo Sancio, Priscila Ferreira de Lima e Souza, et al.

    BackgroundRenoportal anastomosis may restore physiologic portal inflow in selected liver transplant recipients with Yerdel grade IV portal vein thrombosis and splenorenal shunts. We evaluated direct end-to-end reconstruction without an interposition graft.MethodsThis retrospective case series included adult recipients with planned renoportal reconstruction at a liver transplant center in northeastern Brazil between December 2024 and May 2026. Outcomes were analyzed descriptively, with completed reconstructions comprising the primary cohort.ResultsAmong 71 liver transplants, six recipients were considered for renoportal reconstruction, which was completed in five. Uncontrolled intraoperative bleeding prevented completion in one patient, who died in the immediate postoperative period. Among completed cases, median age was 33 years and MELD-Na was 23. All five had splenorenal shunts and underwent direct anastomosis without interposition grafts. Functional portal inflow was maintained in all, without reconstruction-related vascular intervention. Three patients underwent reoperation, none for renoportal failure. Early allograft dysfunction occurred in three of four evaluable patients. All five developed KDIGO stage 3 acute kidney injury; two required temporary renal replacement therapy. Median follow-up was 179 days (range, 72–537). Four patients remained alive; one died on postoperative day 72 following osmotic demyelination syndrome and infectious complications.ConclusionDirect renoportal anastomosis maintained functional portal inflow in selected recipients with Yerdel grade IV thrombosis and splenorenal shunts. Despite substantial postoperative morbidity, no reconstruction-related vascular intervention was required during follow-up. Larger studies with standardized vascular and renal follow-up are needed to establish durability and comparative outcomes.

  • Open Access

    Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain

    by Daiki Soma, Yujin Park, Plamen Mihaylov, Burcin Ekser, Marwan Ghabril, Marco Lacerda, Naga Chalasani, Richard S. Mangus, Chandrashekhar A. Kubal

    Background.: There has been a dramatic increase in obesity in the United States. Several studies have reported conflicting results for the impact of obesity on outcomes of liver transplantation (LT). This study aims to assess the impact of obesity on LT and changes in body mass index (BMI) after transplantation. Methods.: All adult LTs performed at Indiana University between 2001 and 2018 were reviewed. BMIs of recipients were subdivided into 6 categories. Survival outcomes were compared across the subgroup. BMI was followed up in a cohort of patients from 2008 to 2018. Results.: Among 2024 patients, 25% were in class I obesity, 9.3% were in class II obesity, and 1.1% were in class III obesity. There was no significant difference in patient and graft survival at 10-y follow-up with respect to BMI. Among 1004 patients in the subgroup, BMI of all groups except the underweight group declined in the first 3 mo postoperatively; however, the BMI of all groups except the class III obesity group returned to the pre-LT level by 2 y and reached a plateau by 5 y. In the class III obesity group, there was a significant increase in body weight at 5 y. Conclusions.: Class III obesity was not associated with higher mortality in our cohort. Because our cohort is small, it may be underpowered to detect a smaller difference in outcome. From our observation, obesity should not be considered a contraindication for LT. Post-LT interventions are required to prevent significant weight gain for the class III obesity group.


  • Distal allograft pancreatectomy for graft salvage after pancreas transplantation

    by Daiki Soma, Tejas Nikumbh, Richard S Mangus, Andrew J. Lutz, John A. Powelson, Jonathan A Fridell

    Early pancreas allograft failure most commonly results from vascular thrombosis. Immediate surgical intervention may permit pancreas allograft salvage, typically requiring thrombectomy. In cases of partial allograft necrosis secondary to splenic arterial thrombosis, distal allograft pancreatectomy may allow salvage of at least half of the pancreas allograft with retention of function. We retrospectively reviewed four cases of simultaneous pancreas and kidney recipients who required distal allograft pancreatectomy for splenic artery thrombosis with necrosis of the distal pancreas. Three of the four maintained long‐term allograft function with euglycemia independent of insulin at six months to six years of follow‐up, and all patients continue to maintain normal renal allograft function. Early diagnosis and early intervention are essential in order to salvage the pancreas allograft in the case of thrombosis. Distal allograft pancreatectomy can be performed safely and result in excellent long‐term outcomes in select patients.


  • Open Access

    Reconstruction of Aberrant Left Hepatic Artery in Orthotopic Liver Transplantation – Single Center Experience

    by Plamen Mihaylov, Burcin Ekser, Daiki Soma, Andrew Lutz, Jonathan Fridell, Chandrashekhar A. Kubal

    One of the most feared complications in liver transplantation is hepatic arterial thrombosis (HAT). The incidence of HAT in liver transplantation varies from 1.2% and 8%. One of the risk factors for this complication is anatomical complexity of hepatic arterial system. The focus of this short communication is to show our approach in dealing with aberrant left hepatic artery in settings of liver transplantation. This is a single center experience. Between January 2016 and June 2019, we procured and transplanted 357 adult liver allografts. Of these, there were 34 (9.5%) livers with aberrant left hepatic artery. All of them have been reconstructed on bench table. There was no incidence of HAT in the entire cohort with ALHA. The one-year graft survival for this patient cohort was 93.1%. Our surgical approach resulted in a low incidence of HAT of 1% with excellent graft survival.

  • Open Access

    Liver transplantation in recipients with class III obesity: post-transplant outcomes and weight gain

    by Daiki Soma, Yujin Park, Plamen Mihaylov, Burcin Ekser, Marwan Ghabril, Marco Lacerda, Naga Charasani, Richard Shane Mangus, Chandrashekhar Avinash Kubal

    Introduction Over the past decades, there has been a dramatic increase in obesity in the United States. Several studies have reported conflicting results for the impact of obesity on outcomes of liver transplantation (LT). This study aims to assess severe obesity's impact on LT outcomes and changes in body mass index (BMI) after transplantation.Methods All adult LT performed at Indiana University Health University Hospital between July 2001 and December 2018 were reviewed. A retrospective analysis for identified 2024 patients was conducted. BMI of recipients is subdivided into underweight, normal, overweight, class Ⅰ obesity, class Ⅱ obesity, and class Ⅲ obesity (2, respectively). Survival outcomes were compared across the sub-group. Post-transplant BMI was followed up in a smaller cohort of patients receiving LT from January 2008 to December 2018 (n = 1004).Results Among 2024 patients in the analytic cohort, 1.9% were underweight, 24.5% were normal, 32.6% were overweight, 25% were in class Ⅰ obesity, 9.3% were in class Ⅱ obesity, and 1.1% were in class Ⅲ obesity. There was no significant difference in patient and graft survival at 10-year follow-up with respect to recipient obesity. The 1, 3, 5, and 10-year graft and patient survivals in class Ⅲ obesity group were 97.0%, 92.1%, 87.0%, and 79.8% for patient survival and 94.4%, 85.1%, 79.8%, and 72.5% for graft survival. Among 1004 patients identified in the sub-group, BMI of all groups except the underweight group declined in the first three months postoperatively. After the three months, the BMI of all groups except the class Ⅲ obesity group returned to the pre-LT level by two years and reached a plateau by five years. In patients with class Ⅲ obesity, there was a significant increase in body weight at long-term follow-up.Conclusion In this study, class Ⅲ obesity is not associated with higher post-transplant mortality. Obesity, including class Ⅲ obesity, should not be considered a contraindication to LT in the absence of other contraindications. Post-LT interventions are required to prevent significant weight gain in recipients with class Ⅲ obesity.